Latash Investments, LLC

Holdings History for Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (AQST)

Symbol: AQST on Nasdaq
Investment type: Equity / Common Stock, $0.001 par value

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Price	All Holders
31 Dec 2025	1.1%	0%	$1,570,646	243,134	$6.46	Q4 2025
30 Sep 2025	0.99%	0%	$1,359,119	243,134	$5.59	Q3 2025
30 Jun 2025	0.62%	0%	$804,774	243,134	$3.31	Q2 2025
31 Mar 2025	0.58%	0%	$705,089	243,134	$2.90	Q1 2025
31 Dec 2024	0.68%	0%	$865,557	243,134	$3.56	Q4 2024
30 Sep 2024	1.1%	0%	$1,210,807	243,134	$4.98	Q3 2024
30 Jun 2024	0.51%	0%	$632,148	243,134	$2.60	Q2 2024
31 Mar 2024	0.74%	0%	$1,035,751	243,134	$4.26	Q1 2024
31 Dec 2023	0.35%	0%	$491,131	243,134	$2.02	Q4 2023
30 Sep 2023	0.32%	0%	$371,995	243,134	$1.53	Q3 2023
30 Jun 2023	0.32%	0%	$401,171	243,134	$1.65	Q2 2023
31 Mar 2023	0.25%	0%	$277,173	243,134	$1.14	Q1 2023
31 Dec 2022	0.18%	0%	$219,331	243,134	$0.90	Q4 2022
30 Sep 2022	0.23%	0%	$284,000	243,134	$1.17	Q3 2022
30 Jun 2022	0.13%	0%	$156,000	243,134	$0.64	Q2 2022
31 Mar 2022	0.41%	0%	$635,000	243,134	$2.61	Q1 2022
31 Dec 2021	0.59%	0%	$946,000	243,134	$3.89	Q4 2021
30 Sep 2021	0.66%	0%	$1,060,000	243,134	$4.36	Q3 2021
30 Jun 2021	0.61%	0%	$965,000	243,134	$3.97	Q2 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.